Skip to main content

Table 1 Indicators of the immune status in patients with chronic respiratory diseases, mean ± SE

From: Modification of the fatty acid composition of the erythrocyte membrane in patients with chronic respiratory diseases

Indicators Healthy subjects n = 10 Patient with chronic bronchitis, n = 15 Patients with chronic obstructive pulmonary disease n = 15
PAN, % 64.52 ± 0.68 59.90 ± 0.88* 57.52 ± 1.96*
TNFα, pg/ml 2.60 ± 0.03 7.89 ± 1.47*** ×4.3 ± 0.3***
sTNF-RI, pg/ml 789.1 ± 7.10 1595.58 ± 141.53*** 1523.4 ± 11.0***
bFGF, pg/ml 38.3 ± 0.8 38.93 ± 1.54 ×53.9 ± 0.3***
TGF-β, pg/ml 1865.4 ± 11.3 1479.17 ± 19.60** ×48145.0 ± 20.6***
IL-8, pg/ml 11.5 ± 1.9 17.40 ± 1.20*** ×13.4 ± 1.6
  1. PAN – phagocytic activity of the neutrophils. Asteriks indicate significant differences of indicators between patients with respiratory diseases and healthy subjects: * for р < 0.05; ** for р < 0.01; *** for р < 0.001. Asteriks indicate significant differences of fatty acid contents between patients with chronic bronchitis and with chronic obstructive pulmonary disease: × for р < 0.001.